Dynamic Technology Lab Private LTD Regeneron Pharmaceuticals, Inc. Transaction History

Dynamic Technology Lab Private LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $661,228 - $752,090	853 New	853 $749,000
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $487,230 - $592,110	716 New	716 $588,000
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $749,594 - $1.01 Million	1,367 New	1,367 $808,000
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $248,165 - $291,245	-417 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $82,608 - $101,987	-152 Reduced 26.71%	417 $264,000
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $326,623 - $387,466	569 New	569 $344,000
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $263,822 - $311,665	-558 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $45,119 - $55,368	-101 Reduced 15.33%	558 $264,000
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $315,199 - $400,658	659 New	659 $318,000
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $452,885 - $564,680	-1,434 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $514,275 - $673,908	1,434	1,434 $540,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.